About TBG Diagnostics
TBG Diagnostics is a company based in Darra (Australia) founded in 1989. TBG Diagnostics has completed 1 acquisition, including CellGate. TBG Diagnostics offers products and services including Reagents, QzTGSO, Nanopore, QzNGS, and Illumina. TBG Diagnostics operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
- Headquarter Darra, Australia
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TBG Diagnostics
TBG Diagnostics offers a comprehensive portfolio of products and services, including Reagents, QzTGSO, Nanopore, QzNGS, and Illumina.
Essential chemicals for laboratory experiments
Tools for advanced DNA sequencing applications
Systems for real-time genetic analysis
Solutions for next-generation sequencing
Platforms for high-throughput sequencing
Services for HLA typing and assurance
Techniques for sequence-based typing
Probes for targeted genetic detection
Quantitative PCR for gene expression
Automated systems for sample processing
Services for streamlining scientific workflows
Funding Insights of TBG Diagnostics
Detailed funding history for TBG Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TBG Diagnostics
TBG Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CellGate.
Investment portfolio details for TBG Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Oncology drugs were developed by CellGate until its 2008 acquisition.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for TBG Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TBG Diagnostics
Detailed financials for TBG Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tbg Diagnostics Comparisons
Peer comparison for TBG Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TBG Diagnostics
TBG Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| Locked | Locked | Locked |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| Locked | Locked | Locked |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| Locked | Locked | Locked |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of immune monitoring reagents and services for research and clinical use
|
|
| Locked | Locked | Locked |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
Detailed competitors of TBG Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tbg Diagnostics
Complete news archive for TBG Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TBG Diagnostics
TBG Diagnostics was founded in 1989.
TBG Diagnostics is headquartered in Darra, Australia. It is registered at Darra, Queensland, Australia.
TBG Diagnostics was founded in 1989 in Darra, Australia, and operates within the molecular diagnostics sector. Kits, instruments, and software for applications such as HLA typing and DNA extraction are developed and manufactured. Products include automated multichannel pipettes and gel electrophoresis instruments. Progen Pharmaceuticals was acquired in January 2016, followed by RBC Biosciences in August 2016. Majority ownership is held by Medigen Biotechnology Corp of Taiwan.
TBG Diagnostics's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
TBG Diagnostics offers Reagents, QzTGSO, Nanopore, QzNGS, and 6 more products and services.
TBG Diagnostics has made 1 acquisition, including CellGate.